These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 16785115)

  • 21. The use of botulinum toxin type A in the treatment of Frey and crocodile tears syndromes.
    Kyrmizakis DE; Pangalos A; Papadakis CE; Logothetis J; Maroudias NJ; Helidonis ES
    J Oral Maxillofac Surg; 2004 Jul; 62(7):840-4. PubMed ID: 15218563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Not only gustatory sweating and flushing: Signs and symptoms associated to the Frey syndrome and the role of botulinum toxin A therapy.
    Marchese MR; Bussu F; Settimi S; Scarano E; Almadori G; Galli J
    Head Neck; 2021 Mar; 43(3):949-955. PubMed ID: 33247501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Botulinum toxin in the therapy of gustatory sweating.
    Schulze-Bonhage A; Schroder M; Ferbert A
    J Neurol; 1996 Feb; 243(2):143-6. PubMed ID: 8750551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Botulinum toxin for treatment of glandular hypersecretory disorders.
    Laing TA; Laing ME; O'Sullivan ST
    J Plast Reconstr Aesthet Surg; 2008 Sep; 61(9):1024-8. PubMed ID: 18619934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of Frey's syndrome (gustatory sweating) and 'crocodile tears' (gustatory epiphora) with purified botulinum toxin.
    Hofmann RJ
    Ophthalmic Plast Reconstr Surg; 2000 Jul; 16(4):289-91. PubMed ID: 10923977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Management of axillary hyperhidrosis].
    Pomarède N
    Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S125-8. PubMed ID: 19576478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Frey syndrome: diagnosis and treatment].
    Budziński R
    Otolaryngol Pol; 1999; 53(6):687-91. PubMed ID: 10763320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Botulinum toxin type B (Myobloc).
    Baumann L; Black L
    Dermatol Surg; 2003 May; 29(5):496-500; discussion 500. PubMed ID: 12752517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Injectable botulinum toxin as a treatment for plantar hyperhidrosis: a case study.
    Vlahovic TC; Dunn SP; Blau JC; Gauthier C
    J Am Podiatr Med Assoc; 2008; 98(2):156-9. PubMed ID: 18347128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effective treatment of frontal hyperhidrosis with botulinum toxin A.
    Kinkelin I; Hund M; Naumann M; Hamm H
    Br J Dermatol; 2000 Oct; 143(4):824-7. PubMed ID: 11069464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recurrent gustatory sweating (Frey syndrome) after intracutaneous injection of botulinum toxin type A: incidence, management, and outcome.
    Laccourreye O; Akl E; Gutierrez-Fonseca R; Garcia D; Brasnu D; Bonan B
    Arch Otolaryngol Head Neck Surg; 1999 Mar; 125(3):283-6. PubMed ID: 10190799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Botulinum Toxin Treatment of Autonomic Disorders: Focal Hyperhidrosis and Sialorrhea.
    Hosp C; Naumann MK; Hamm H
    Semin Neurol; 2016 Feb; 36(1):20-8. PubMed ID: 26866492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism of gustatory flushing in Frey's syndrome.
    Drummond PD
    Clin Auton Res; 2002 Jun; 12(3):144-6. PubMed ID: 12269544
    [No Abstract]   [Full Text] [Related]  

  • 34. The place of botulinum toxin type A in the treatment of focal hyperhidrosis.
    Lowe N; Campanati A; Bodokh I; Cliff S; Jaen P; Kreyden O; Naumann M; Offidani A; Vadoud J; Hamm H
    Br J Dermatol; 2004 Dec; 151(6):1115-22. PubMed ID: 15606505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Botulinum toxin for treatment of Frey's syndrome: report of two cases.
    Teive HA; Troiano AR; Robert F; Iwamoto FM; Maniglia JJ; Mocellin M; Werneck LC
    Arq Neuropsiquiatr; 2003 Jun; 61(2A):256-8. PubMed ID: 12806506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of axillary and palmar hyperhidrosis with botulinum toxin.
    Goldman A
    Aesthetic Plast Surg; 2000; 24(4):280-2. PubMed ID: 10954791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Writer's block: "texting" impairment as a complication of botulinum toxin type A therapy for palmar hyperhidrosis.
    Lehman JS
    Arch Dermatol; 2011 Jun; 147(6):752. PubMed ID: 21690551
    [No Abstract]   [Full Text] [Related]  

  • 38. Botulinum toxin therapy in Frey's syndrome: a retrospective study of 440 treatments in 100 patients.
    Jansen S; Jerowski M; Ludwig L; Fischer-Krall E; Beutner D; Grosheva M
    Clin Otolaryngol; 2017 Apr; 42(2):295-300. PubMed ID: 27513469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary frontal hyperhidrosis successfully treated with low doses of botulinum toxin A as a useful alternative to surgical treatment.
    Santana-Rodríguez N; Clavo-Varas B; Ponce-González MÁ; Jarabo-Sarceda JR; Pérez-Alonso D; Ruiz-Caballero JA; Olmo-Quintana V; Atallah Yordi N; Fiuza-Pérez MD
    J Dermatolog Treat; 2012 Feb; 23(1):49-51. PubMed ID: 20964567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Botulinum toxin type A for Frey's syndrome: a preliminary prospective study.
    Laccourreye O; Muscatelo L; Naude C; Bonan B; Brasnu D
    Ann Otol Rhinol Laryngol; 1998 Jan; 107(1):52-5. PubMed ID: 9439389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.